AAN

Peter Nakaji, MD: The State of Science for Epilepsy Surgery

May 29, 2020

The chair of the Department of Neurosurgery at Banner-University Medical Center discusses the current state of the science being done in the realm of epilepsy surgery.

Second Dose of Ubrogepant Is Safe and Effective in Acute Migraine

May 22, 2020

The study author, director of MedStar Georgetown Headache Center, and associate professor of neurology at MedStar Georgetown University Hospital discussed the findings of a pooled analysis of the ACHIEVE I and II studies of ubrogepant.

Andrew Blumenfeld, MD: Long-Term OnabotulimuntoxinA Use in the COMPEL Study

May 20, 2020

The director of the Headache Center of Southern California discussed the findings of the study, as well as what these data might suggest about how onabotulinumtoxinA fits into the shifting landscape of chronic migraine care.

Ofatumumab Shines in Pooled Comparative Analysis in Relapsing Multiple Sclerosis

May 20, 2020

The neurologist at the Mellen Center for Multiple Sclerosis Treatment and Research at Cleveland Clinic discussed how the agent might fit into the treatment landscape if its sBLA is approved by the FDA later this year.

Nusinersen Shows Efficacy in Infantile- and Late-Onset Spinal Muscular Atrophy

May 19, 2020

The new data further cemented the therapy’s consistent safety profile from previous studies as well as demonstrated a newfound durability in patients with later-onset spinal muscular atrophy.

Steve Chung, MD: Cannabidiol in Tuberous Sclerosis Complex

May 13, 2020

The neurologist at Banner-University Medicine Neuroscience Institute offered his perspective on data from an open-label safety assessment of cannabidiol (Epidiolex) in the treatment of tuberous sclerosis complex.